Keefe Bruyette Lowers Price Target for Lemonade to $45

Keefe Bruyette has lowered its stock price target for insurance technology company Lemonade to $45. This revision indicates that the brokerage has made an update to its assessment of the company. The price target cut may lead investors to reassess their expectations regarding Lemonade's performance. Keefe Bruyette's decision reflects market analysts' views on the company's financial outlook. Lemonade is known as a company operating in the digital insurance sector. The price target change stands out as part of analyst evaluations on the stock. Investors can shape their positions by following brokerages' price target updates and company news. However, such revisions alone are not sufficient for an investment decision. This is not investment advice.

📊 LMND — Piyasa Yorumu

▼ down · 55%

Keefe Bruyette's reduction of its price target to $45 could create short-term negative pressure on the stock. However, since the $45 target remains above the current level of $39.55, this is not a 'sell' signal but rather an expectation adjustment. The technical picture is already weak: the price is below the SMA20 and SMA50, the MACD is in negative territory, and the RSI at 34 is close to the oversold threshold. Although the low RSI level increases the possibility of a short-term relief rally, weak momentum and the news flow support the downside. Therefore, I expect a moderately downward trend in the 1-3 day outlook.

RSI 14

34.2

MACD

-0.99

24h Δ

-3.50%

Canlı Grafikler